Search clinical trials for: COMBIVENT Inhalation Aerosol

Total 1975 results

Boehringer Ingelheim

Terminated

Combivent® HFA-propelled Compared to CFC-propelled Metered Dose Inhaler in Patients With COPD (Chronic Obstructive Pulmonary Disease)

Pulmonary Disease, Chronic Obstructive
The First Affiliated Hospital of Soochow University

Recruiting

The Effect of Precise Aerosol Inhalation Nursing on Sputum Excretion in Elderly Patients With Lung Surgery

Inhalation

China
University of Roma La Sapienza
Queen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention Srl

Completed

Sulfureous Water Therapy in Viral Respiratory Diseases (STWandRVD)

Post Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 Syndrome

Italy
Boehringer Ingelheim

Completed

A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Clinical Study to Evaluate the Pharmacokinetics and Safety of BDP HFA Nasal Aerosol

Allergic Rhinitis
Boehringer Ingelheim

Terminated

Ventilator Adapters for Combivent Respimat

Pulmonary Disease, Chronic Obstructive

United States
Amphastar Pharmaceuticals, Inc.

Completed

Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics

Asthma | Shortness of Breath | Wheezing | Bronchospasm

United States
Boehringer Ingelheim

Completed

Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive
Amphastar Pharmaceuticals, Inc.

Terminated

Randomized, Placebo/Active Crossover Dose-ranging Study for Safety and Efficacy in Asthma Patients.

Asthma

United States
Boehringer Ingelheim

Terminated

Comparison of Safety and Efficacy of COMBIVENT HFA to COMBIVENT (CFC) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive
Amphastar Pharmaceuticals, Inc.

Completed

Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients

Asthma

United States
Cipla Ltd.

Not yet recruiting

BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma

Bronchial Asthma

United States
Boehringer Ingelheim

Completed

Efficacy and Safety of Tiotropium Compared to Salmeterol and Placebo in Patients With Chronic Obstructive Bronchitis (COPD)

Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline

Completed

ELLIPTA™ vs. MDI Inhaler Preference Study, in Adult Subjects With Asthma

Asthma

United States
Neutec Ar-Ge San ve Tic A.Ş

Withdrawn

Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD

Chronic Obstructive Pulmonary Disease
Universiti Kebangsaan Malaysia Medical Centre

Completed

Impact of Covid-19 Aerosol Box On Intubation Success Rate

Intubation; Difficult or Failed

Malaysia
Boehringer Ingelheim

Completed

Safety and Tolerability of COMBIVENT® HFA as Compared to COMBIVENT® CFC and Placebo HFA in Healthy Male and Female Subjects

Healthy
LEO Pharma

Completed

LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

Psoriasis Vulgaris

United States, Canada, Germany, United Kingdom, France, Poland
Amphastar Pharmaceuticals, Inc.

Terminated

Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults

Asthma

United States
Boehringer Ingelheim

Completed

Trial to Determine the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to ATROVENT® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim

Completed

Study of the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to the Market Standard, Atrovent® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive
Ola Blennow, MD, PhD
Karolinska University Hospital; Danderyd Hospital; Centrallasarettet Västerås

Active, not recruiting

Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19) (HALT)

Pneumonia, Viral | Covid-19 | Sars-CoV2

Sweden
University of Pennsylvania
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Completed

Acute Effects of E-Cigarette Aerosol Inhalation

Endothelial Dysfunction | Biochemical Markers

United States
Amphastar Pharmaceuticals, Inc.

Terminated

4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Asthma

Asthma

United States
Massachusetts General Hospital

Recruiting

Quantifying Viral Load in Respiratory Particles That Are Generated by Children and Adults With COVID-19 Infection

COVID-19

United States
University of Malaya

Unknown

Taiwan "Aerosol Box" Versus UMMC "Intubation Box"

COVID-19 | Airway

Malaysia
Sunovion

Terminated

A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects

Asthma

United States
Centre Hospitalier Universitaire de Nice

Recruiting

Migraine and High Flow Oxygenotherapy at the Emergency Department (MiOx) (MiOx)

Migraine

France
Pearl Therapeutics, Inc.

Completed

Pharmacokinetics and Safety Study of PT010 in Healthy Subjects

COPD

United States
Derince Training and Research Hospital

Completed

Effect of Using Barrier Devices for Intubation in COVID-19 Patients

COVID-19 | Intubation, Intratracheal

Turkey
Intech Biopharm Ltd.

Completed

Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90mcg Per Actuation in Healthy Volunteers Under Fasting Conditions

Healthy

Taiwan
Astellas Pharma Inc
Astellas Pharma US, Inc.

Completed

A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma

Asthma

United States
Prof. Aviram Nissan

Not yet recruiting

Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial

Metastatic Colorectal Cancer | Peritoneal Carcinomatosis | Colon Adenocarcinoma
Istituto Ortopedico Rizzoli

Completed

Effect of Sulfur Thermal Water on Circulating H2S Levels and Markers of Bone Metabolism in Osteopenic Subjects. (FORST3)

Osteoporosis | Hydrogen Sulfide

Italy
University of Oxford
University of Birmingham

Terminated

MVA85A Aerosol vs Intramuscular Vaccination in Adults With Latent Mycobacterium Tuberculosis (M. tb) Infection

Tuberculosis

United Kingdom
Intech Biopharm Ltd.

Completed

Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108 mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90 mcg Per Actuation in Healthy Volunteers Under Fasting Conditions

Healthy

Taiwan
Mayo Clinic

Withdrawn

Safety Study of Inhaled Saline in Acute Lung Injury

Pulmonary Edema
Lawson Health Research Institute

Terminated

Non Invasive Positive Pressure Ventilation to Minimize Aerosolization for COVID 19

COVID-19

Canada
Rush University Medical Center

Terminated

Humidity Therapy for Spontaneously Breathing Tracheostomy Patients

Respiratory Failure

United States
Pearl Therapeutics, Inc.

Completed

Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPD (telos)

Chronic Obstructive Pulmonary Disorder

United States, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Czechia
Amphastar Pharmaceuticals, Inc.

Completed

Epinephrine Inhalation Aerosol USP, CLINICAL STUDY-B3 FOR ASSESSMENT OF PHARMACOKINETICS

Asthma

United States
LEO Pharma

Completed

A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123) (LP0113-1123)

Skin and Connective Tissue Diseases

France
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease.

Chronic Obstructive Pulmonary Disease

China
Pearl Therapeutics, Inc.

Completed

Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD

Chronic Obstructive Pulmonary Disease

United States, Germany, United Kingdom, China, Taiwan, Korea, Republic of, Japan, Czechia, Hungary, Poland, Russian Federation
University of Pennsylvania
Drexel University

Completed

Biocontainment Device for Aerosol Generating Procedures

Droplet Spread | Protective Device (Physical Object) | Aerosol Disease

United States
University Hospital, Tours
Institut National de la Santé Et de la Recherche Médicale, France

Recruiting

Effect of Intrapulmonary Percussion Ventilation on Deposition of Inhaled Aerosols in Idiopathic Pulmonary Fibrosis (AEROPERC)

Idiopathic Pulmonary Fibrosis

France
University of Manitoba
Manitoba Institute of Child Health

Terminated

Inhalation of Low Concentration of CO2 in Preterm Infants Not Responding to Caffeine for the Treatment of Apnea

Apnea of Prematurity

Canada
Intech Biopharm Ltd.

Recruiting

Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients With Stable Mild Asthma

Mild Asthma

Taiwan, India
Ache Laboratorios Farmaceuticos S.A.

Withdrawn

Efficacy Study of Two Silicon-based Products to Treat Scars (Kelofin)

Scars
KidSIM Simulation Program
Canadian Institutes of Health Research (CIHR)

Not yet recruiting

Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study

COVID-19 | Cardiac Arrest | Coronavirus

Canada, United States

3

Subscribe